NEELS GUIDO J 4

4 · TELA Bio, Inc. · Filed Jun 11, 2026

AI-generated summary of this filing

Updated Jun 11, 2026

TELA Bio (TELA) Director Guido J. Neels Receives Equity Awards

What Happened

Guido J. Neels, a director of TELA Bio, received a package of equity awards on June 9, 2026 totaling 58,485 shares: 11,925 RSUs, 11,675 RSUs, 17,550 option-based awards, and 17,335 option-based awards. Each line was recorded at an acquisition price of $0.00 (standard for grants/awards).
These were grants (award/acquisition), not open-market purchases or sales — they increase potential future ownership if vesting conditions are met.

Key Details

Transaction date: June 9, 2026; Form 4 filed June 11, 2026 (appears timely).
Awards granted: 11,925 RSUs (F1), 11,675 RSUs (F2), 17,550 option-type awards (F3), 17,335 option-type awards (F4). Total = 58,485 shares.
Price: $0.00 recorded for each grant (reflects grant, not cash purchase).
Shares owned after transaction: not specified in the filing summary provided.
Notable vesting terms:
- F1 (11,925 RSUs): vest in three equal annual installments beginning June 9, 2027, subject to continued service.
- F2 (11,675 RSUs): vest on the earlier of June 9, 2027, the next annual meeting, or a Change in Control, subject to continued service.
- F3 (17,550 option awards): vest in 36 equal monthly installments beginning June 9, 2026, subject to continued service.
- F4 (17,335 option awards): vest on the earlier of June 9, 2027, the next annual meeting, or a Change in Control, subject to continued service.

Context

These entries are awards/grants to a director and do not represent buying or selling in the open market. Grants are commonly used for compensation and retention; they become economically relevant only as they vest and, for options, if exercised.
For retail investors, new grants increase potential future dilution but do not by themselves signal immediate insider buying or selling.

Form 4

Period: 2026-06-09

Director

Transactions

Award
Common Stock
[F1]
2026-06-09+11,925→ 11,925 total
Award
Common Stock
[F2]
2026-06-09+11,675→ 23,600 total
Award
Stock Option (Right to Buy)
[F3]
2026-06-09+17,550→ 17,550 total
Exercise: $0.94Exp: 2036-06-09→ Common Stock (17,550 underlying)
Award
Stock Option (Right to Buy)
[F4]
2026-06-09+17,335→ 17,335 total
Exercise: $0.94Exp: 2036-06-09→ Common Stock (17,335 underlying)

Footnotes (4)

[F1]These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F2]These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F3]The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F4]The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Signature

/s/ Megan Smeykal, Attorney-in-Fact|2026-06-11

1 file